太仓市生物医药产业发展现状及对策研究  

Research on the development current status and countermeasures of biomedical industry in Taicang

作　　者：方月琴[1] 陈雪峰[1] 苗向阳[1] Fang Yueqin;Chen Xuefeng;Miao Xiangyang(College of Biomedicine,Suzhou Chien-Shiung Institute of Technology,Suzhou 215411,China)

机构地区：[1]苏州健雄职业技术学院生物医药学院,江苏苏州215411

出　　处：《江苏科技信息》2021年第1期1-3,共3页Jiangsu Science and Technology Information

基　　金：太仓市软科学项目,项目名称:关于提升我市生物医药产业基础能力和产业链水平的路径研究;江苏省现代教育技术研究2019年度课题,项目编号:2019-R-69843;2019年度苏州健雄职业技术学院“课程思政”教学改革试点课程。

摘　　要：2020年4月,苏州市提出力争10年内建成国际知名的"中国药谷"。按照苏州生物医药产业集群的定位,太仓紧抓苏州打造世界级生物医药产业地标的"风口",提出力争打造临沪生物医药产业集聚高地。文章分析了太仓市生物医药产业发展中存在的问题,提出构筑标准化的、具有可持续发展的"政产学研用"生物医药平台,不断提升产业智能化水平,提升产业基础能力,提高人才储备,补全、补齐产业链条,为苏州达成规模万亿的世界级"中国药谷"贡献太仓力量。In April 2020, Suzhou proposed striving to build an internationally famous"China Drug Valley"within 10 years. According to the positioning of the biomedical industry cluster in Suzhou, Taicang firmly grasped the opportunity of Suzhou aiming to create the world-class biological medicine industry landmark, and proposed striving to create the biomedical industry cluster highland adjacent to Shanghai. This paper analyzes the problems existing in the development of Taicang biomedical industry, and proposes constructing a standardized and sustainable biological pharmaceutical platform of"government, industry, university, research and application", continuously improving the level of industrial intelligence, improving the basic ability of industry, improving the reserve of talents, completing and supplementing the industrial chain, and contributing Taicang power to achieve world-class"China Drug Valley"with the scale of thousands of trillion in Suzhou.

关 键 词：太仓 生物医药 发展现状 研究对策 

分 类 号：F062.9[经济管理—政治经济学]